Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Neurological outcome in cerebrotendinous xanthomatosis treated with chenodeoxycholic acid: early versus late diagnosis.

Clinical neuropharmacology - 1 Jan 2000

Yahalom Gilad, Tsabari Rakefet, Molshatzki Noa, Ephraty Lilach, Cohen Hofit, Hassin-Baer Sharon

Abstract excerpt

OBJECTIVE: To present the long-term neurological outcome of Jewish Israeli patients with cerebrotendinous xanthomatosis (CTX) after several years of chenodeoxycholic acid (CDCA) treatment. METHODS: A cross sectional observational study of all patients with a diagnosis of CTX followed in a referra...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cholestanetriol 26-Monooxygenase
Share to Delayed Diagnosis
Share to Early Diagnosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Educational Status

Share to Employment

Share to Gastrointestinal Agents

Share to Nervous System Diseases

Share to Xanthomatosis, Cerebrotendinous

Source

Identifiers

PMID: 23673909
DOI: 10.1097/WNF.0b013e318288076a

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23673909-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Neurological outcome in cerebrotendinous xanthomatosis treated with chenodeoxycholic acid: early versus late diagnosis.PMID 23673909Read ↗

Update on cerebrotendinous xanthomatosis.Semantic proximity Read ↗

Nationwide survey on cerebrotendinous xanthomatosis in Japan.Semantic proximity Read ↗

Cerebrotendinous xanthomatosis: a comprehensive review of pathogenesis, clinical manifestations, diagnosis, and managementSemantic proximity Read ↗

Clinical, biochemical, and molecular insights into Cerebrotendinous Xanthomatosis: A nationwide study of 100 Turkish individuals.Semantic proximity Read ↗

Cerebrotendinous xanthomatosis in Spain: clinical, prognostic, and genetic survey.Semantic proximity Read ↗

Cerebrotendinous xanthomatosis: molecular diagnosis enables presymptomatic detection of a treatable disease.Semantic proximity Read ↗

Spinal Cerebrotendinous Xanthomatosis: An Easily Overlooked Treatable DisorderSemantic proximity Read ↗

Cerebrotendinous Xanthomatosis occurs at high frequency in Ashkenazi Jews.Semantic proximity Read ↗

[Clinical and genetics characteristics of adult-onset cerebrotendinous xanthomatosis: analysis of a Chinese pedigree].Semantic proximity Read ↗

Cerebrotendinous xanthomatosis: clinical course, genotypes and metabolic backgrounds.Semantic proximity Read ↗

[Cerebrotendinous xanthomatosis is a rare disorder, which requires a specific treatment].Semantic proximity Read ↗

Pathophysiology of cerebrotendinous xanthomatosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.